5 Things You Didn’t Know About Medpace’s Biorepository Services
Medpace Biorepository, a CAP accredited facility, is a key component of Medpace Central Labs and the full-service model.
Read MoreMedpace Biorepository, a CAP accredited facility, is a key component of Medpace Central Labs and the full-service model.
Read MoreMedpace is pleased to announce the addition of three scientists to our Central Laboratory leadership team.
Read MoreIn a recent article published in Clinical Leader, Ed Miseta, Chief Editor highlights Medpace’s partnership with Locus Biosciences and their development of crPhage™, a bacteriophage that have been engineered to deliver the CRISPR-Cas3 constructs into the target bacteria.
Read MoreAs part of our efforts to expand laboratory services and capabilities, specifically in Asia, Medpace has relocated our central laboratory facilities from Beijing to Shanghai. The Shanghai lab is a larger laboratory (with a 180% increase in space) and has allowed Medpace to expand capabilities to better service our client’s clinical trials in China.
Read MoreWe sat down with Christopher Daniels, Director, Clinical Laboratory Services at Medpace, to discuss regulations and standards for biomarkers, validation process for central labs, and the benefit of working with an experienced partner.
Read MoreMedpace is committed to keeping Sponsors on PACE to maintain regular activity during this irregular time.
Read MoreIn a process-oriented industry that breathes deeply from a standard set of regulations, it is easy to see the importance of each storage unit in the repository and the value of a biorepository risk mitigation plan.
Read MoreTo serve our Sponsors in their COVID-19 programs, Medpace has expedited COVID-19 assay validations to meet clinical trial testing standards.
Read MoreAs part of our efforts to expand laboratory services and capabilities, Medpace’s central lab in Belgium recently completed extensive expansions including a new modern laboratory building at the Leuven facility. Highlights include an expanded onsite PhD Team, new molecular suite, flow cytometry services grow, biorepository updates, and logistics/kit building expansion
Read MoreDr. El Mustapha Bahassi, Associate Director of Clinical Laboratories at Medpace, highlights the biomarker landscape in immuno-oncology clinical research.
Read MoreImportant Cookie Information – This message will only appear once.
Medpace websites use cookies. By continuing to browse the site you are agreeing to our use of cookies.
For more details about cookies and their use, please see our Privacy Policy.